In this regard, Yuanlin Wan et al. proposed a solution to the issues of immunosuppression and over-growth in TRIM-infected cancers by incorporating TRIM-targeted antimicrobials into anti-tumor therapy (Wang et al., 2024). This evidence concerns the gene TRAT1 and neoplasm.